The aim of this study is to evaluate both pharmaceutical therapy and advanced treatment
techniques for infertile patients requiring in-vitro fertilization utilizing donor eggs.
Drug: Progesterone in Oil
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01465373
Ages eligible for Study
21 Years to 49 Years
Genders eligible for Study
Accepts Healthy Volunteers
Age 21-34 years of age
Normal ovarian reserve, defined as FSH <10 and AFC >10
Medical evaluation consistent with FDA criteria for donor inclusion Donor Oocyte Recipients
Documented history of infertility requiring donor oocyte for optimal fertility potential
Documentation of a normal uterine cavity by hysteroscopy, hysterosonogram, or HSG within 1 year of study screening
Fresh or Frozen Sperm
Abnormal ovarian reserve, defined as FSH <10, AFC>10, prior poor response to controlled ovarian hyper-stimulation(COHS)
Failure to meet FDA criteria for donor approval (risk factor and medical evaluation)
Previous history of poor response to COHS Donor Oocyte Recipients:
Uncontrolled hypothyroidism, hyperprolactinemia, or systemic disease that may interfere with study treatment
Active thrombophlebitis or thromboembolic disorders, or a history of hormone associated thrombophlebitis or thromboembolic disorders
Surgically aspirated sperm (TESE)
2 or more clinical pregnancy losses (excluding aneuploidy for previous autologous cycles)
Clinically significant gynecologic pathology or uterine abnormality, such as submucosal fibroids > 5 cm, communicating hydrosalpinx, uncorrected uterine septum, undiagnosed vaginal bleeding, endometrial atypia, or any other condition that could adversely affect pregnancy outcomes
History of 2 or more failed IVF donor cycles
All locations for NCT01465373
United States (1)
Fertility Centers of Illinois
Chicago, Illinois, United States, 60610
View full eligibility
Tris trial is registered with FDA with number: NCT01465373. The sponsor of the trial is Fertility Centers of Illinois and it is looking for 10 volunteers for the current phase.
Official trial title: Comparison of the Effectiveness of Micronized Vaginal Progesterone (Endometrin, Ferring) Vs. Progesterone in Oil for Luteal Phase Support in Donor Egg Recipient IVF Cycles Utilizing Previously Vitrified Donor Oocytes
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.